Kelly Blackburn
Vermogen: 35 279 $ op 31-07-2026
Vermogen: 35 279 $ op 31-07-2026
Kelly Blackburn currently works at Bach Pharma, Inc., as Chief Executive Officer & Director from 2016 and CervoMed, Inc., as Executive Vice President-Clinical Development from 2025.
Ms. Blackburn also formerly worked at Millennium Pharmaceuticals, Inc., as Director-Clinical & Safety Operations from 2002 to 2006, aTyr Pharma, Inc., as Vice President-Clinical Affairs from 2013 to 2016, Vertex Pharmaceuticals, Inc., as Vice President-Clinical Development Operations from 2006 to 2012, and EIP Pharma, Inc., as Senior Vice President-Clinical Development from 2018 to 2023.
Ms. Blackburn received her undergraduate degree from the University of New Hampshire, graduate degree from Quinnipiac College, Inc., and graduate degree from Cambridge College Lima SRL.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CERVOMED INC. 0,09% | 17-04-2026 | 13.674 ( 0,09% ) | 35 279 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CERVOMED INC. | Hoofd Techniek/Wetenschap/O&O | 16-08-2023 |
Bach Pharma, Inc.
Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | 15-07-2016 |
| Bedrijven | Functie | Einde |
|---|---|---|
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Corporate Officer/Principal | 01-08-2023 |
| ATYR PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2016 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-09-2012 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01-08-2006 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Bach Pharma, Inc.
Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quinnipiac College, Inc.
Quinnipiac College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge College Lima SRL
Cambridge College Lima SRL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
CervoMed, Inc.
CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau